Jonas Grossman

New York, New York, United States
Jonas Grossman is Partner and President of Chardan, where he oversees the firm’s banking and capital markets activities. He has broad transactional experience having led or managed more than 400 transactions since joining Chardan in 2003. Under Mr. Grossman’s leadership, Chardan has become one of the most notable underwriters, advisors and sponsors of SPACs, having underwritten 79 transactions raising $10.4billion with zero liquidations. Chardan has also served as advisor to 18 SPAC transactions.

Additionally, Mr. Grossman is President and Chief Executive Officer of Chardan’s 6th sponsored SPAC, Chardan Healthcare Acquisition 2 Corp, a healthcare focused SPAC. He was the Chief Executive Officer and President of Chardan Healthcare Acquisition Corp. from March 2018 until its merger in October 2019 with BiomX (NYSE: PHGE) where he remains on the board of directors. Mr. Grossman is currently a director of LifeSci Acquisition Corp. Additionally, Mr. Grossman has served as a founding partner for Cornix Advisors, LLC, a New York based hedge fund.

From 2001 until 2003, Mr. Grossman worked at Ramius Capital Group, LLC, a global multi-strategy hedge fund where he served as Vice President and Head Trader. He holds a B.A. in Economics from Cornell University and an M.B.A. from NYU’s Stern School of Business.
Speaking In
2:00 PM - 3:00 PM (EST)
Tuesday, February 16
Biotech SPACs (special purpose acquisition companies) have reached record levels in 2020. A recent…